novartis hits acquisition trail swiss drugmaker novartis has announced 5.65bn euros 7.4bn 3.9bn of purchases to make its sandoz unit the world s biggest generic drug produce the deal will see novartis sandoz business overtake israel s teva pharmaceuticals as the world s biggest maker of generic novartis said that it would be able to make cost savings of about 200m a year following the acquisition the strong growth outlook for sandoz which will create jobs is expected to partially compensate for necessary reductions in the work force the firm said in a statemen